Health ❯ Diabetes

Type 2 Diabetes

Treatment Options Medications Risk Factors Medication Management GLP-1 Receptor Agonists Complications Prediabetes Treatment Weight Management

Study Finds Small Rise in Smell and Taste Diagnoses Among People on GLP‑1 Diabetes Drugs

Prospective studies are needed to test whether the drugs directly affect chemosensory nerves.

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

Trial Finds Dexcom G7 Improves Glycemic Control in Non‑Insulin Type 2 Diabetes

EMS’s Ozivy Cleared by Anvisa as First Synthetic Semaglutide Pen After Patent Expiry

Type 2 Diabetes Rising Fast in UK Women Under 40, Charity Warns

Mexico Issues Alert After Falsified Ozempic Lot Identified

Study Finds Post-Diagnosis GLP-1 Use Linked to Lower Risk of Cancer Progression

Generic Semaglutide Hits Canadian Pharmacy Shelves

New Data Link GLP-1 Weight-Loss Drugs to Fewer Sick Days and Lower Disease Risks

Mounjaro Overtakes Keytruda as World’s Best-Selling Drug in Q1 2026

Study Ties Obesity and Diabetes to Pancreatic Cancer via Six Inflammatory Genes

Hershey Links Mint and Gum Sales Jump to GLP-1 Drug Use

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link

Exercising to Your Body Clock Yields Bigger Heart and Metabolic Gains, Study Finds

Anvisa Rejects Three Semaglutide and Liraglutide Drug Filings in Brazil

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

GLP-1 Drugs Tied to Lower Addiction Risk and Harms in Large VA Study

GLP-1 Drugs Tied to Lower Addiction Risk and Fewer Severe Outcomes in Major BMJ Analysis